Treatment options in patients with pancreatic cancer: A 10-year multicenter epidemiological investigation in China. [PDF]
Sun WY+9 more
europepmc +1 more source
Comparison of the Actions of 5-Fluorouracil and Ftorafur in Escherichia coli
Priscilla P. Saunders, Lian‐Yu Chao
openalex +1 more source
Advances in Molecularly Imprinted Polymers for Bone Biomarker Detection and Therapeutic Applications
This review highlights the emerging applications of molecularly imprinted polymers (MIPs) in bone regeneration and diagnosis. MIPs facilitate osteogenic treatments by guiding stem cell differentiation and delivering bioactive molecules and enable precise detection of bone turnover biomarkers via MIP‐based sensors, offering promising strategies for next‐
Ren Yang+8 more
wiley +1 more source
Gut microbiome with <i>RAS</i> mutation and chemotherapy response in patients with advanced or metastatic colorectal cancer: a pilot, exploratory study. [PDF]
Kim JH+5 more
europepmc +1 more source
Methoxy‐phenylacrylonitriles (2a–c) are synthesized and characterized by fourier‐transform infrared spectroscopy, nuclear magnetic resonance spectroscopy, and X‐ray crystallography (for 2a,b). Compound 2b shows selective cytotoxicity against MCF‐7 cells (IC50: 34 μM) and enhances activity against Gram‐positive bacteria. Molecular docking reveals strong
Leyla Babali Özen+8 more
wiley +1 more source
Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy. [PDF]
Jafari Z+2 more
europepmc +1 more source
Incorporating deep eutectic solvents into polymer‐based drug delivery systems (DDS) offers a sustainable route to enhance solubility, modify drug release, and create dual‐function carriers. This review explores how DES influence polymer structures and DDS performance, highlighting future prospects in personalized, responsive pharmaceutical technologies.
Nining Nining+3 more
wiley +1 more source
Comparison of 5-Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer. [PDF]
Lee TS+13 more
europepmc +1 more source